Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

Economics & Human Biology, published by Elsevier, is a prestigious journal that serves as an interdisciplinary platform at the intersection of economics and health sciences. With ISSN 1570-677X and E-ISSN 1873-6130, this journal analyzes the implications of economic factors on human health and biological outcomes. As a recognized leader in its field, it has earned a remarkable Q1 ranking in both the Economics, Econometrics and Finance (miscellaneous) and Health (social science) categories for 2023, reflecting its significant impact within the academic community, as evidenced by its Scopus rank of 88 out of 371 and a 76th percentile ranking in Health social sciences. Highlighting key issues such as health disparities, economic policy impacts on health, and the biological determinants of economic behavior, the journal encourages innovative research that bridges these critical domains. Researchers, professionals, and students seeking to contribute to or stay informed on emerging trends in health economics will find this journal an invaluable resource. Explore the latest findings and engage with a community dedicated to advancing our understanding of the interplay between economics and human biology.

JOURNAL OF DRUG ISSUES, published by SAGE PUBLICATIONS INC, serves as a pivotal platform for researchers and professionals dedicated to the multifaceted exploration of drug-related topics across various fields, including health, medicine, psychiatry, and public health. With an ISSN of 0022-0426 and an E-ISSN of 1945-1369, this esteemed journal has maintained a consistent output since its inception in 1971 and is set to continue its contributions through 2024. Reflecting its high academic standards, it has achieved a Q2 ranking in Health (Social Science) and Q3 rankings in several related categories, underscoring its relevance and influence among scholarly work. The journal is indexed in Scopus, with respectable rankings in various medical and health-related disciplines, highlighting its role as an essential resource for those invested in the vigorous discourse surrounding drug issues. Although not an open-access publication, the journal ensures that access to its extensive research findings remains available to a broad audience, solidifying its importance in advancing knowledge and informing best practices in the field.

Tobacco Use Insights is a leading open-access journal dedicated to advancing the understanding of tobacco use and its implications for public health. Published by SAGE Publications Ltd, this journal provides a platform for innovative research, critical reviews, and practice-oriented articles that span the diverse dimensions of tobacco consumption, cessation, policy impacts, and prevention strategies. With a commitment to facilitating knowledge dissemination since its inception in 2009, Tobacco Use Insights serves an international audience of researchers, health professionals, and students who are engaged in the ongoing fight against tobacco-related health issues. The journal is indexed and accessible across multiple databases, reinforcing its influence within the field and ensuring wide visibility for its contributors. The journal's insightful contributions play an essential role in shaping effective tobacco control policies and fostering healthier communities globally.

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

Tobacco Prevention & Cessation is a vital open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing knowledge in the fields of public health and tobacco control. Established in 2015, this journal provides a platform for the dissemination of high-quality research aimed at reducing tobacco use and improving cessation strategies worldwide. With an impressive impact across various categories, including a Q1 ranking in Health Professions, the journal is integral to the global health community, highlighting critical issues related to tobacco prevention and cessation practices. Researchers and practitioners can benefit from access to cutting-edge studies designed to inform policies and practices, making this journal an essential resource for those committed to combating tobacco-related health challenges. Operating under an open-access model, Tobacco Prevention & Cessation ensures that impactful research is available to all, furthering its mission of fostering public health education and awareness.

Tobacco Induced Diseases is a leading open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing research in the critical fields of tobacco-related health issues, epidemiology, and public policy. With an ISSN of 1617-9625, this esteemed journal has been nurturing academic discourse since its inception in 2002, situated in the picturesque backdrop of Heraklion, Crete. Recognized for its rigorous publication standards and impactful contributions, the journal proudly holds a Q1 ranking in Health (Social Science) and consistently ranks within the top quarters for both Medicine (Miscellaneous) and Public Health, Environmental, and Occupational Health. With impressive Scopus rankings, including #67 in Health and #99 in Medicine, it serves as an essential platform for researchers, professionals, and students aiming to understand and address the pressing challenges associated with tobacco use and its long-term health implications. As the journal converges its research coverage from 2009 to 2024, it invites contributions that span multidisciplinary perspectives and innovative approaches to tackling tobacco-induced diseases.

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.